Topic

Texas

A collection of 418 issues

How to Get Vanflyta (Quizartinib) Covered by Cigna in Texas: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Vanflyta (Quizartinib) Covered by Cigna in Texas Vanflyta (quizartinib) requires prior authorization from Cigna and typically involves step therapy requirements. Most approvals take 7-14 days with complete documentation. Fastest path: 1) Confirm FLT3-ITD positive AML diagnosis with genetic testing results, 2) Document failure/intolerance of preferred FLT3
7 min read

Renewing Poteligeo (Mogamulizumab-kpkc) Approval with Cigna in Texas: 2025 Requirements, Timeline, and Appeal Options

Quick Answer: Renewing Your Poteligeo Coverage with Cigna in Texas Poteligeo (mogamulizumab-kpkc) requires annual renewal with Cigna, typically 30-60 days before your current authorization expires. Submit updated TNMB staging, pathology reports, flow cytometry results (for Sézary syndrome), proof of clinical benefit, and specialist consultation notes. Cigna reviews within 72 hours
6 min read

UnitedHealthcare's Coverage Criteria for Hetlioz (Tasimelteon) in Texas: What Counts as "Medically Necessary"?

Answer Box: Getting Hetlioz Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Hetlioz (tasimelteon) with strict medical necessity criteria. Coverage is limited to totally blind adults with Non-24-Hour Sleep-Wake Disorder or confirmed Smith-Magenis Syndrome patients (ages 3-15 for oral suspension, 16+ for capsules). Step therapy with melatonin is
6 min read